ARTICLE SUMMARY:
Scientists behind some of the innovations that made CRISPR and other engineering biology technologies so powerful for drug R&D have founded a diagnostics company. They’re starting with rapid COVID-19 testing.
CRISPR, the extraordinary gene editing tool that is making drug development more effective, is revolutionizing scientific research from top to bottom. Now, years after it has infiltrated the therapeutic world, top-flight scientists behind some of the most important CRISPR breakthroughs are looking at its applications in diagnostics, including SARS-CoV-2 testing.
